Effectiveness and safety of risdiplam in Chinese adolescents and adults with spinal muscular atrophy: a prospective real-world study
Evidence for the efficacy of risdiplam in adolescents and adults with 5q spinal muscular atrophy (SMA) has been demonstrated in clinical trials, but its sustained effectiveness and safety in real-world settings, particularly in Chinese adults, are still limited. We evaluated the effectiveness and safety of risdip...